Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Brugia malayi | ImpB/MucB/SamB family protein | 0.002 | 1 | 0.5 |
Leishmania major | DNA polymerase eta, putative | 0.002 | 1 | 0.5 |
Leishmania major | DNA polymerase kappa, putative,DNA polymerase IV, putative | 0.002 | 1 | 0.5 |
Echinococcus multilocularis | dna polymerase eta | 0.002 | 1 | 0.5 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.002 | 1 | 0.5 |
Mycobacterium ulcerans | DNA polymerase IV | 0.002 | 1 | 0.5 |
Mycobacterium tuberculosis | Conserved hypothetical protein | 0.002 | 1 | 0.5 |
Trypanosoma cruzi | DNA polymerase eta, putative | 0.002 | 1 | 0.5 |
Loa Loa (eye worm) | ImpB/MucB/SamB family protein | 0.002 | 1 | 0.5 |
Giardia lamblia | DINP protein human, muc B family | 0.002 | 1 | 0.5 |
Schistosoma mansoni | DNA polymerase eta | 0.002 | 1 | 0.5 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.002 | 1 | 0.5 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.002 | 1 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.002 | 1 | 1 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.002 | 1 | 1 |
Echinococcus granulosus | terminal deoxycytidyl transferase rev1 | 0.002 | 1 | 0.5 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.002 | 1 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.002 | 1 | 0.5 |
Leishmania major | DNA polymerase kappa, putative | 0.002 | 1 | 0.5 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.002 | 1 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.002 | 1 | 1 |
Trypanosoma brucei | unspecified product | 0.002 | 1 | 1 |
Trypanosoma brucei | DNA polymerase eta, putative | 0.002 | 1 | 1 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.002 | 1 | 1 |
Schistosoma mansoni | rab geranylgeranyl transferase alpha subunit | 0.002 | 1 | 0.5 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.002 | 1 | 1 |
Echinococcus multilocularis | terminal deoxycytidyl transferase rev1 | 0.002 | 1 | 0.5 |
Mycobacterium ulcerans | DNA polymerase IV | 0.002 | 1 | 0.5 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.002 | 1 | 1 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.002 | 1 | 0.5 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.002 | 1 | 1 |
Echinococcus granulosus | dna polymerase kappa | 0.002 | 1 | 0.5 |
Schistosoma mansoni | terminal deoxycytidyl transferase | 0.002 | 1 | 0.5 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.002 | 1 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.002 | 1 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.002 | 1 | 1 |
Mycobacterium tuberculosis | Possible DNA-damage-inducible protein P DinP (DNA polymerase V) (pol IV 2) (DNA nucleotidyltransferase (DNA-directed)) | 0.002 | 1 | 0.5 |
Trichomonas vaginalis | DNA polymerase IV / kappa, putative | 0.002 | 1 | 0.5 |
Echinococcus multilocularis | dna polymerase kappa | 0.002 | 1 | 0.5 |
Entamoeba histolytica | deoxycytidyl transferase, putative | 0.002 | 1 | 0.5 |
Echinococcus granulosus | dna polymerase eta | 0.002 | 1 | 0.5 |
Trichomonas vaginalis | DNA polymerase eta, putative | 0.002 | 1 | 0.5 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.002 | 1 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Control (functional) | = 4 % | Activity to induce the elevation of triglycerides in plasma lipids of male Wistar rats | ChEMBL. | 3612689 |
Control (functional) | = 10 % | Activity to induce the elevation of phospholipids in plasma lipids of male Wistar rats | ChEMBL. | 3612689 |
Control (functional) | = 14 % | Activity to induce the elevation of alpha/beta cholesterol ratio in plasma lipids of male Wistar rats | ChEMBL. | 3612689 |
Control (functional) | = 20 % | Activity to induce the elevation of HDL(High Density Lipoproteins)-Cholesterol in plasma lipids of male Wistar rats | ChEMBL. | 3612689 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.